Viral complementation gene therapy for stress-responsive crop protection

Technology
Conceptual
University

A novel 'lock and key' crop protection paradigm using transgenic plants and deconstructed viral vectors to deliver plant protective genes only under stress conditions. This technology enables targeted gene therapy that activates only when plants experience abiotic or biotic stress, minimizing agricultural inputs while maximizing yield protection.

Overview

This technology introduces a new paradigm in crop protection through viral complementation gene therapy. The approach uses transgenic plants engineered to express viral functions such as coat proteins or replication machinery, which complement a deconstructed virus vector that has these functions replaced with plant protective genes. This 'lock and key' system ensures that gene therapy delivery occurs only when the plant is experiencing stress, as the viral functions are expressed under plant stress promoters.

The core innovation addresses a fundamental limitation in plant biology: plants cannot predict the duration of stressful conditions and therefore respond with conservative overcompensation. By controlling the degree of plant compensation through stress-triggered viral complementation, this technology enables precise, condition-specific crop treatment. This approach minimizes unnecessary agricultural inputs such as fertilizers and pest control products while maximizing yield protection during critical stress periods.

Technical specifications

Key features:

  • Deconstructed viral vector system: A virus engineered with essential functions (coat protein, movement, and/or replication) removed and replaced with heterologous plant protective genes
  • Transgenic complementation plants: Plants expressing the removed viral functions under stress-inducible promoters, providing the 'key' to activate the vector
  • Stress-responsive activation: Viral functions expressed only under plant stress promoters, ensuring treatment occurs only when beneficial
  • Versatile cargo capacity: Removed viral functions can be replaced with reporter genes, artificial microRNAs, or plant protective genes
  • Validated complementation: Demonstrated that coat protein, movement, and replication functions can each be provided by the transgenic plant
  • High signal-to-noise reporting: Newly developed quantitative luciferase-based reporter genes for exceptional detection sensitivity

How it works: A virus lacking coat protein cannot move throughout the plant, replicate, or encapsidate for transmission. When a transgenic plant expressing these missing functions encounters stress, the stress promoters activate expression of the viral complementation functions, enabling the deconstructed virus to deliver its protective gene cargo specifically to stressed plants.

Technology readiness level

This technology is at an early-to-mid stage of development. Proof-of-concept work has demonstrated that removed viral functions can be successfully replaced with heterologous genes including artificial microRNAs. The research team is seeking support for a follow-on experiment that has received APHIS-BRS regulatory permits for a BSL3 insect transmission study. This proposed work will use a deconstructed geminivirus and complementary transformed tomato plants to provide proof-of-principle validation, including insect-based transmission testing using high-sensitivity luciferase reporters. Successful completion of these studies would advance the technology toward field evaluation and eventual commercial development.


About Penn State University

Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.